Prevalence, Bacterial Patterns and Factors Associated with Pin Tract Infections Among Patients with Percutaneous Pin at Bugando Medical Centre, Mwanza, Tanzania.
Material type:
TextPublisher number: Wurzburg Road 35, BMC Premises, Post Code: 33102: P. O Box 1464, Mwanza – Tanzania: Phone: +255 28 298 3384: Fax: +255 28 298 3386: Email: vc@bugando.ac.tz :www.bugando.ac.tzLanguage: English Publication details: Mwanza, Tanzania: Catholic University of Health and Allied Sciences [CUHAS - Bugando] : 2019Description: x; 63 PagesSubject(s): Summary: ABSTRACT
Background: Percutaneous pins remain the common implants for fractures stabilization. The main complication which affect patients with percutaneous pins is pin tract infections (PTI). The prevalence of PTI and the causative bacteria vary in different setting
Objective: This study was designed to determine the prevalence, bacteria isolates and factors associating with PTI at Bugando Medical Centre
Methodology: This was a hospital based analytical cross sectional study which involved 91 participants with 358 percutaneous pins on different body sites. Study was conducted at BMC orthopedic outpatient clinic from March to June 2019. Discharge sample (pus or serous) from infected pins were collected for culture and sensitivity. Data entry and analysis was done using Microsoft excel (2016) and Stata v.12 respectively.
Results: The median age of the participants was 28 [IQR of 22 to 39] and majority of them were male 71 (77.8%). Commonest reason for pin fixation was open fracture 70 (77.8%). Uniplanar external fixators were used in 47 patients (49.0%). Two frequent bacteria isolates were S. aureus 24 (41.4%) and Acinetobacter spp. 17 (29.3%). Ciprofloxacin was sensitive to up to … and ….. S. aureus and Acenetobacter spp., respectively. Parallel pin fixation technique was found to protect patients with percutaneous pin from getting PTI (OR 0.1; 95% CI 0.01 – 0.74; P-value 0.025).
Conclusion: Pin tract infection is still prevalent in our setup with S. aureus being the most common bacteria and remain sensitive to Ciprofloxacin. Use of parallel pins has shown to have a protective role against PTI. We recommend empirical Ciprofloxacin in patients with PTI as a first line antibiotic.
| Item type | Current library | Collection | Status | Barcode | |
|---|---|---|---|---|---|
| POSTGRADUATE DISSERTATIONS | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | NFIC | 1 | PD0346 |
ABSTRACT
Background: Percutaneous pins remain the common implants for fractures stabilization. The main complication which affect patients with percutaneous pins is pin tract infections (PTI). The prevalence of PTI and the causative bacteria vary in different setting
Objective: This study was designed to determine the prevalence, bacteria isolates and factors associating with PTI at Bugando Medical Centre
Methodology: This was a hospital based analytical cross sectional study which involved 91 participants with 358 percutaneous pins on different body sites. Study was conducted at BMC orthopedic outpatient clinic from March to June 2019. Discharge sample (pus or serous) from infected pins were collected for culture and sensitivity. Data entry and analysis was done using Microsoft excel (2016) and Stata v.12 respectively.
Results: The median age of the participants was 28 [IQR of 22 to 39] and majority of them were male 71 (77.8%). Commonest reason for pin fixation was open fracture 70 (77.8%). Uniplanar external fixators were used in 47 patients (49.0%). Two frequent bacteria isolates were S. aureus 24 (41.4%) and Acinetobacter spp. 17 (29.3%). Ciprofloxacin was sensitive to up to … and ….. S. aureus and Acenetobacter spp., respectively. Parallel pin fixation technique was found to protect patients with percutaneous pin from getting PTI (OR 0.1; 95% CI 0.01 – 0.74; P-value 0.025).
Conclusion: Pin tract infection is still prevalent in our setup with S. aureus being the most common bacteria and remain sensitive to Ciprofloxacin. Use of parallel pins has shown to have a protective role against PTI. We recommend empirical Ciprofloxacin in patients with PTI as a first line antibiotic.
There are no comments on this title.
Click on an image to view it in the image viewer